Optical Control of Cytokine Production Using Photoswitchable Galactosylceramides

Nina Hartrampf1, Toshiyuki Seki2,3, Andreas Baumann1

  • 1Department of Chemistry, New York University, 100 Washington Square East, New York, NY, 10003, USA.

Insights

Researchers developed light-activatable α-galactosylceramides for cancer immunotherapy. These novel photolipids show potential for controlling immune responses, offering new avenues in photoimmunotherapy.

Area of Science:

  • Immunology
  • Organic Chemistry
  • Photochemistry

Background:

  • α-Galactosylceramides are key in cancer immunotherapy by activating natural killer T cells (NKT).
  • NKT cell activation leads to pro-inflammatory cytokine release, crucial for immune modulation.
  • Controlling NKT cell activity offers therapeutic potential.

Purpose of the Study:

  • To synthesize and evaluate photochromic derivatives of KRN-7000 for light-modulated cancer immunotherapy.
  • To design photoswitchable glycolipids that control pro-inflammatory cytokine production.
  • To explore new directions in photoimmunotherapy using light-sensitive lipids.

Main Methods:

  • Synthesis of novel azobenzene-containing α-galactosylceramide analogues.
  • Biological evaluation of synthesized compounds for NKT cell activation.
  • Assessment of cytokine production (e.g., IFN-γ) upon light activation.

Main Results:

  • Developed photochromic α-galactosylceramides with light-switchable activity.
  • The azobenzene derivative α-GalACer-4 demonstrated enhanced potency compared to KRN-7000 upon 370 nm light activation.
  • Demonstrated control over pro-inflammatory cytokine production.

Conclusions:

  • Photochromic α-galactosylceramides offer a novel approach to modulate NKT cell responses.
  • These photolipids could advance mechanistic understanding of cytokine production.
  • This research opens new therapeutic possibilities in photoimmunotherapy.